MARIA RODRIGUEZ-BARRADAS to Ritonavir
This is a "connection" page, showing publications MARIA RODRIGUEZ-BARRADAS has written about Ritonavir.
Connection Strength
0.106
-
Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus. Pharmacotherapy. 2008 Mar; 28(3):323-30.
Score: 0.073
-
Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination. Clin Vaccine Immunol. 2016 06; 23(6):524-529.
Score: 0.033